retatrutide clinical trials efficacy safety Retatrutide, an experimental weight-loss drug, has not been approved by Lilly's triple agonist, retatrutide, delivered
Pay in 4 interest-free payments of $7.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 22 - Nov 27



























